Lexeo Therapeutics, Inc.（LXEO）内部人交易：高管与董事近期交易
过去 18 个月，共有 7 位内部人为 Lexeo Therapeutics, Inc.（LXEO）报告了 58 笔 Form 4 交易（最近一笔 2026-09-28）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-28 | Townsend Richard Nolan | Chief Executive Officer | 买入 | 2,306 | $6,097 |
| 2026-09-28 | Otero Jose Manuel | Chief Operating Officer | 买入 | 2,110 | $5,579 |
| 2026-09-28 | Bhalla Narinder Pal | Chief Medical Officer | 买入 | 2,714 | $9,713 |
| 2026-08-19 | Townsend Richard Nolan | Chief Executive Officer | 卖出 | 3,345 | $16,562 |
| 2026-08-19 | Otero Jose Manuel | Chief Operating Officer | 卖出 | 1,304 | $6,464 |
| 2026-08-19 | Tamayo Louis Edward | Chief Financial Officer | 卖出 | 4,117 | $20,203 |
| 2026-07-01 | Tamayo Louis Edward | Chief Financial Officer | 卖出 | 4,641 | $20,838 |
| 2026-07-01 | Otero Jose Manuel | Chief Operating Officer | 买入 | 12,060 | $0 |
| 2026-07-01 | Tamayo Louis Edward | Chief Financial Officer | 买入 | 12,000 | $0 |
| 2026-07-01 | Bhalla Narinder Pal | Chief Medical Officer | 买入 | 55,000 | $0 |
| 2026-07-01 | Townsend Richard Nolan | Chief Executive Officer | 卖出 | 25,947 | $116,243 |
| 2026-07-01 | Otero Jose Manuel | Chief Operating Officer | 卖出 | 4,666 | $20,904 |
| 2026-07-01 | Townsend Richard Nolan | Chief Executive Officer | 买入 | 67,000 | $0 |
| 2026-07-01 | Bhalla Narinder Pal | Chief Medical Officer | 卖出 | 22,306 | $98,593 |
| 2026-05-20 | Townsend Richard Nolan | Chief Executive Officer | 卖出 | 3,342 | $16,911 |
| 2026-05-20 | Otero Jose Manuel | Chief Operating Officer | 卖出 | 1,302 | $6,601 |
| 2026-04-07 | Townsend Richard Nolan | Chief Executive Officer | 卖出 | 55,000 | $312,950 |
| 2026-03-17 | Townsend Richard Nolan | Chief Executive Officer | 买入 | 2,623 | $6,925 |
| 2026-03-17 | Otero Jose Manuel | Chief Operating Officer | 买入 | 5,930 | $15,655 |
| 2026-02-20 | Otero Jose Manuel | Chief Operating Officer | 卖出 | 3,016 | $19,302 |
| 2026-02-20 | Otero Jose Manuel | Chief Operating Officer | 卖出 | 721 | $6,684 |
| 2026-02-20 | Townsend Richard Nolan | Chief Executive Officer | 卖出 | 10,173 | $64,904 |
| 2026-02-17 | Bhalla Narinder Pal | Chief Medical Officer | 买入 | 49,500 | $0 |
| 2026-02-06 | Tamayo Louis Edward | Chief Financial Officer | 买入 | 44,665 | $0 |
| 2026-02-06 | Otero Jose Manuel | Chief Operating Officer | 买入 | 65,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-28